DRUG TARGETING USING NONMAGNETIC AND MAGNETIC ALBUMIN-GLOBULIN MIX MICROSPHERES OF MEFENAMIC-ACID

被引:11
作者
LALLA, JK
AHUJA, PL
机构
[1] Department of Pharmaceutics, Prin. K. M. Kundnani College of Pharmacy, Worli Bombay
关键词
D O I
10.3109/02652049109021856
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Optimum conditions for the preparation of non-magnetic and magnetic microspheres of albumin-globulin mix (alglomix) containing mefenamic acid have been standardized. The effect of various parameters has been investigated with regard to the appearance, yield, drug content and encapsulation efficiency. The physicochemical parameters of the microspheres such as density, particle size distribution, surface topography and wall thickness, as well as the magnetite contained within the magnetic microspheres, have been determined. The infrared spectroscopic analysis confirmed the encapsulation of the drug and absence of free drug on the surface of the microspheres. The X-ray diffraction analysis confirmed that the crystallinity of the drug remained unchanged indicating thereby that no complex formation had taken place between core and coat materials. The in vitro release profiles of the microspheres have been studied. An attempt has also been made to check the in vivo efficacy in rats.
引用
收藏
页码:37 / 52
页数:16
相关论文
共 20 条
[1]  
Burger J.J., Tomlinson E., McVie J.G., Microparticles intended for microvasculature blockage. Drug incorporation and release, Drug Targeting, pp. 81-94, (1985)
[2]  
Davis S.S., Mills S.N., Tomlinson E., Chemically cross-linked albumin microspheres for the controlled release of incorporated Rose Bengal after intramuscular injection into rabbits, Journal of Controlled Release, 4, pp. 293-302, (1987)
[3]  
Deasy P.B., Polymeric procedures for biodegradable micro- and nanocapsules and particles, Microencapsulation and Releated Drug Processes, pp. 219-240, (1984)
[4]  
Gesler R.M., Gravin P.J., Klamer B., Robinson R.U., Thompson C.R., Gibson W.R., Wheeler F.C., Carlson R.G., The biologic effects of polystyrene latex particles administered intravenously to rats—a collaborative study, Bulletin of the Parenteral Drug Association, 27, pp. 101-113, (1973)
[5]  
Ishizaka T., Endo K., Koishi M., Preparation of egg albumin microcapsules and microspheres, Journal of Pharmaceutical Sciences, 70, pp. 358-363, (1981)
[6]  
Ishizaka T., Koishi M., In vitro drug release from egg albumin microcapsules, Journal of Pharmaceutical Sciences, 72, pp. 1057-1061, (1983)
[7]  
Lee T.K., Sokolowski T.D., Royer G.P., Serum albumin beads: An injectable, biodegradable system for the sustained release of drugs, Science, 213, pp. 233-235, (1981)
[8]  
Longo W.E., Iwata H., Lindheimer T.A., Goldberg E.P., Preparation of hydrophilic albumin microspheres using polymeric dispersing agents, Journal of Pharmaceutical Sciences, 71, pp. 1323-1328, (1982)
[9]  
McConnell J.F., N-(2,3-xylyl) anthranilic acid, C<sub>15</sub>H<sub>15</sub>No<sub>2</sub>, Mefenamic acid, Crystal Structure Communications, 5, pp. 861-864, (1976)
[10]  
Pal P.R., Pal T.K., Studies on sulphamethoxazole microcapsules in reference to the effect of micrometric properties on release characteristics, Indian Drugs, 24, pp. 430-437, (1987)